Pulmonary aspergillosis and invasive disease in AIDS: Review of 342 cases

Chest

Volumn 114, Issue 1, 1998, Pages 251-262

  Mylonakis, Eleftherios ^a   Barlam, Tamar F ^b   Flanigan, Timothy ^a,c   Rich, Josiah D ^a  

^a BROWN UNIVERSITY   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c MIRIAM HOSPITAL   (United States)

Author keywords

AIDS; Amphotericin B; Aspergillosis; Fungal infection; HIV; Itraconazole; Liposomal amphotericin B

Indexed keywords

AMPHOTERICIN B; CORTICOSTEROID; FLUCYTOSINE; ITRACONAZOLE; TERBINAFINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CLINICAL FEATURE; DISEASE PREDISPOSITION; DRUG EFFICACY; DRUG PENETRATION; FEMALE; HELPER CELL; HUMAN; LUNG ASPERGILLOSIS; LUNG BIOPSY; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEUTROPENIA; PRIORITY JOURNAL; REVIEW; STEROID THERAPY; THORAX RADIOGRAPHY; TREATMENT OUTCOME;

EID: 0031871318     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.114.1.251     Document Type: Article

References (166)

1. Anaissie E. Opportunistic mycoses in the immunocompromised host: experience at a cancer center and review. Clin Infect Dis 1992; 14(suppl 1):S43-53
2. Klapholz A, Salomon N, Perlman DC, et al. Aspergillosis in the acquired immunodeficiency syndrome. Chest 1991; 100:1614-18
3. Minamoto GA, Barlam TF, van der Els NJ. Invasive aspergillosis in patients with AIDS. Clin Infect Dis 1992; 14:66-74
4. Addrizzo-Harris DJ, Harkin TJ, McGuinness G, et al. Pulmonary aspergilloma and AIDS: a comparison of HIV-infected and HIV-negative individuals. Chest 1997; 111: 612-18
5. Denning DW, Follansbee SE, Scolaro M, et al. Pulmonary aspergillosis in the acquired immunodeficiency syndrome. N Engl J Med 1991; 324:654-62
6. Judson MA, Sahn SA. Endobronchial lesions in HIV-infected individuals. Chest 1994; 105:1314-23
7. Kemper CA, Hostetler JS, Follansbee SE, et al. Ulcerative and plaque-like trancheobronchitis due to infection with Aspergillus in patients with AIDS. Clin Infect Dis 1993; 17:344-52
8. Denning DW, Stevens DA. Antifungal and surgical treatment of invasive aspergillosis: review of 2,121 published cases. Rev Infect Dis 1990; 12:1147-1201
9. Lortholary O, Meyohas MC, Dupont B, et al. Invasive aspergillosis in patients with acquired immunodeficiency syndrome: report of 33 cases: French cooperative study group on aspergillosis in AIDS. Am J Med 1993; 95:177-87
10. Clarke A, Skelton J, Fraser RS. Fungal trancheobronchitis: report of nine cases and review of the literature. Medicine 1991; 70:1-14
11. Meyer RD, Rosen P, Armstrong D. Phycomycosis complicating leukemia and lymphoma. Ann Intern Med 1972; 77:871-79
12. Young RC, Bennett JE, Vogel CL, et al. Aspergillosis: the spectrum of the disease in 98 patients. Medicine 1970; 49:147-73
13. Kramer MR, Denning DW, Marshall SE, et al. Ulcerative tracheobronchitis after lung transplantation: a new form of invasive aspergillosis. Am Rev Respir Dis 1991; 144:552-56
14. Katzenstein AL, Liebow AA, Friedman PJ. Bronchocentric granulomatosis, mucoid impaction, and hypersensitivity reactions to fungi. Am Rev Respir Dis 1975; 111:497-537
15. Denning DW. Aspergillus trancheobronchitis [letter]. Clin Infect Dis 1994; 19:1176-77
16. Khoo SH, Denning DW. Invasive aspergillosis in patients with AIDS. Clin Infect Dis 1994; 19(suppl 1):S41-48
17. Kauffman CA. Quandary about treatment of aspergillomas persists. Lancet 1996; 347:1640
18. Denning DW. Diagnosis and management of invasive aspergillosis. Curr Clin Top Infect Dis 1996; 16:277-99
19. Decker CF, Parenti DM. Invasive aspergillosis in patients with HIV infection: report of two patients and a review of the literature. J Acquir Immune Defic Syndr Hum Retrovirol 1991; 4:603-06
20. Pursell KJ, Telzak EE, Armstrong D. Aspergillus species colonization and invasive disease in patients with AIDS. Clin Infect Dis 1992; 14:141-48
21. Singh N, Yu VL, Rihs JD. Invasive aspergillosis in AIDS. South Med J 1991; 84:822-27
22. Tumbarello M, Ventura G, Caldarola G, et al. An emerging opportunistic infection in HIV patients: a retrospective analysis of 11 cases of pulmonary aspergillosis. Eur J Epidemiol 1993; 9:638-44
23. Zachgo W, Mikloweit P, Ebermann F. Diagnosis of localized Pneumocystis carinii and Aspergillus growth in two HIV-infected patients by ultrasonically guided percutaneous lung biopsy. Chest 1994; 105:1285-86
24. Britton CB, Mesa-Tejada R, Fenoglio CM, et al. A new complication of AIDS: thoracic myelitis caused by herpes simplex virus. Neurology 1985; 35:1071-74
25. Nagasaki M, Harada T, Torii I, et al. An autopsy case of acquired immune deficiency syndrome (AIDS) with preceding aplastic anemia. Pathol Int 1994; 44:850-56
26. Wallace MR, Kanak RJ, Newton JA, et al. Invasive aspergillosis in patients with AIDS [letter]. Clin Infect Dis 1994; 19:222
27. Grosse G, Staib F, Seibold M, et al. Invasive aspergillosis - an AIDS typical opportunistic infection? [abstract No. MBP 95]. In: The scientific and social challenge: abstracts/ Fifth International Conference on AIDS, Montreal, Quebec, Canada, June 4-9, 1989. Ottawa: International Research Development Centre, 1989
28. Mylonakis E, Kwakwa H, Flanigan T, et al. Extrapulmonary invasive aspergillosis in AIDS patients [abstract No. Mo. B. 1232]. In: Program and abstracts of the XI International Conference on AIDS, Vancouver, 1996
29. Keister R, Salvato P, Thompson C. Tracheal rupture caused by aspergillosis and Nocardia: a case report [abstract No. We. B. 3321]. In: Program and abstracts of the XI International Conference on AIDS, Vancouver, 1996
30. Lissen E, Wichmann I, Jimenez JM, et al. AIDS in haemophilia patients in Spain [letter]. Lancet 1983; 1:992-93
31. Wright M, Fikrig S, Haller JO. Aspergillosis in children with acquired immune deficiency. Pediatr Radiol 1993; 23:492-94
32. Froland SS, Oppedal B, Digranes S, et al. Acquired immunodeficiency syndrome (AIDS): clinical, immunological, pathological, and microbiological studies of the first case diagnosed in Norway. Scand J Gastroenterol 1985; 107(suppl):82-93
33. Pervez NK, Kleinerman J, Kattan M, et al. Pseudomembranous necrotizing bronchial aspergillosis: a variant of invasive aspergillosis in a patient with hemophilia and acquired immune deficiency syndrome. Am Rev Respir Dis 1985; 131:961-63
34. Asnis DS, Chitkara RK, Jacobson M, et al. Invasive aspergillosis: an unusual manifestation of AIDS. N Y State J Med 1988; 88:653-55
35. Wright JL, Lawson JL, Chan N, et al. An unusual form of pulmonary aspergillosis in two patients with the acquired immunodeficiency syndrome. Am J Clin Pathol 1993; 100: 57-59
36. Fairley CK, Kent SJ, Street A, et al. Invasive aspergillosis in AIDS. Aust N Z J Med 1991; 21:747-49
37. Staples CA, Kang EY, Wright JL, et al. Invasive pulmonary aspergillosis in AIDS: radiographic, CT, and pathologic findings. Radiology 1995; 196:409-14
38. Shetty F, Giri N, Gonzalez CE, et al. Invasive aspergillosis in human immunodeficiency virus-infected children. Pediatr Infect Dis J 1997; 16:216-21
39. Denning DW. Therapeutic outcome in invasive aspergillosis. Clin Infect Dis 1996; 23:608-15
40. Sambeat MA, Gurgui M, Ausima V, et al. Pulmonary aspergillosis in patients with AIDS [abstract No. PoB 3248]. In: Program and abstracts of the Eighth International Conference on AIDS (Amsterdam). Amsterdam: CONGREX Holland BV, 1992
41. Meyohas MC, Cadranel J, Poirot JL, et al. Invasive pulmonary aspergillosis (IPA) in 15 patients with AIDS: East Paris CISIH group [abstract No. PoB 3346]. In: Program and abstracts of the Eighth International Conference on AIDS (Amsterdam). Amsterdam: CONGREX Holland BV, 1992
42. Abe T. Clinical, immunological, and virological aspects in Japanese hemophiliacs and AIDS patients. AIDS Res 1986; 2(suppl 1):S141-46
43. Anderson VM, di Maio TM, Gloster E, et al. Autopsy disgnosis of infectious diseases in women with AIDS [abstract No. PoC 4724]. In: Program and abstracts of the Eighth International Conference on AIDS (Amsterdam). Amsterdam: CONGREX Holland BV, 1992
44. Andersson M, Huang L, Newman MD, et al. Aspergillus fumigatus: an unusual cause of empyema in a patient with AIDS [abstract No. Tu. B. 2196]. In: Program and abstracts of the XI International Conference on AIDS, Vancouver, 1996.
45. Arcidiacono MI, Cantaluppi P. Itraconazole in pulmonary aspergillosis [abstract No. PO-B09-1388]. In: Program and abstracts of the Ninth International Conference on AIDS/ Fourth STD World Congress (Berlin). London: Wellcome Foundation, 1993
46. Armbruster C, Schalleschak J, Vetter N, et al. Pleural effusions in human immunodeficiency virus-infected patients: correlation with concurrent pulmonary diseases. Acta Cytol 1995; 39:698-700
47. Denning DW, Tucker RM, Hanson LH, et al. Itraconazole in opportunistic mycoses: cryptococcosis and aspergillosis. J Am Acad Dermatol 1990; 23:602-07
48. Denning DW, Lee JY, Hostetler JS, et al. NIAID mycoses study group multicenter trial of oral itraconazole therapy for invasive aspergillosis. Am J Med 1994; 97:135-44
49. Dorman SE, Sax PE. Salvage adjunctive corticosteroid therapy for disseminated Mycobacterium avium complex infection in patients with AIDS [abstract No. We. B. 3366]. In: Program and abstracts of the XI International Conference on AIDS, Vancouver, 1996
50. Guarda LA, Luna MA, Smith JL, et al. Acquired immune deficiency syndrome: postmortem findings. Am J Clin Pathol 1984; 81:549-57
51. Höhler T, Schnutgen M, Mayer WJ, et al. Pulmonary aspergilloma in a patient with AIDS. Thorax 1995; 50:312-13
52. Hui AN, Koss MN, Meyer PR. Necropsy findings in acquired immunodeficiency syndrome: a comparison of premortem diagnoses with postmortem findings. Hum Pathol 1984; 15:670-76
53. Januszewska M, Staples C, Lawson L, et al. Aspergillosis: an opportunistic infection of advanced HIV disease [abstract No. PO-B09-1376]. In: Program and abstracts of the Ninth International Conference on AIDS/Fourth STD World Congress (Berlin). London: Wellcome Foundation, 1993
54. Jones PG, Cohen RL, Batts DH, et al. Disseminated histoplasmosis, invasive pulmonary aspergillosis, and other opportunistic infections in a homosexual patient with acquired immunodeficiency syndrome. Sex Trans Dis 1983; 10:202-04
55. Just-Nubling G, Ganger G, Keul HG, et al. Invasive Aspergillus infections (IA) in AIDS: a rising problem in Frankfurt [abstract No. PoB. 3337]. In: Program and abstracts of the Eighth International Conference on AIDS (Amsterdam). Amsterdam: CONGREX Holland BV, 1992
56. Just-Nubling G, Ganger G, Hettenkofer M, et al. Therapeutic outcome in AIDS patients with aspergillosis lung infection [abstract No. PO-B09-1409]. In: Program and abstracts of the Ninth International Conference on AIDS/Fourth STD World Congress (Berlin). London: Wellcome Foundation, 1993
57. Klaudel S, Fruhaufl L, Michels B, et al. HIV-associated wasting syndrome-therapy with mammalian cell-derived recombinant human growth hormone (R-HGH) [abstract No. Mo. B. 1384]. In: Program and abstracts of the XI International Conference on AIDS, Vancouver, 1996
58. Knani L, Maslo C, Lucet JC, et al. Overwhelming aspergillosis with positive blood cultures in an AIDS patient [abstract No. PuB 7286]. In: Program and abstracts of the Eighth International Conference on AIDS (Amsterdam). Amsterdam: CONGREX Holland BV, 1992
59. Lombardo GT, Anandarao N, Lin CS, et al. Fatal hemoptysis in a patient with AIDS-related complex and pulmonary aspergilloma. N Y State J Med 1987; 87:306-08
60. Lucas SB, Hounnou A, Peacock C, et al. The mortality and pathology of HIV infection in a west African city. AIDS 1993; 7:1569-79
61. Maiello A, Sciandra M, Calvo MM, et al. Fungal infections: prevalence in HIV infection [abstract No. Tu. B. 2194]. In: Program and abstracts of the XI International Conference on AIDS, Vancouver, 1996
62. Maltez F, Serrano A, Proenca R. Simultaneous infection with Rhodococcus equi, Aspergillus fumigatus and Serattia marcescens in an AIDS patients [abstract No. Tu. B. 2175]. In: Program and abstracts of the XI International Conference on AIDS, Vancouver, 1996
63. Marchevsky A, Rosen MJ, Chrystal G, et al. Pulmonary complications of the acquired immunodeficiency syndrome: a clinicopathologic study of 70 cases. Hum Pathol 1985; 16:659-70
64. Marlowe S, Loveless M, Ward D, et al. Invasive aspergillosis (IA) in AIDS: Health Research Network [abstract No. PO-B09-1417]. In: Program and abstracts of the Ninth International Conference on AIDS/Fourth STD World Congress (Berlin). London: Wellcome Foundation, 1993
65. Martinez-Ocana JC, Romeu J, Llatjos M, et al. Goiter as a manifestation of disseminated aspergillosis in a patient with AIDS. Clin Infect Dis 1993; 17:953-54
66. McLeod DT, Neil P, Robertson VJ, et al. Pulmonary diseases in patients infected with the human immunodeficiency virus in Zimbabwe, Central Africa. Trans R Soc Trop Med Hyg 1989; 83:694-97
67. Michels B, Rust M, Sedlmeyer I, et al. Management of obstructive Aspergillus trancheobronchitis in a patient with AIDS - a case report [abstract No. We. B. 3316]. In: Program and abstracts of the XI International Conference on AIDS, Vancouver, 1996
68. Miller WT Jr, Sais GJ, Frank I, et al. Pulmonary aspergillosis in patients with AIDS: clinical and radiographic correlations. Chest 1994; 105:37-44
69. Moran CR, Suster S, Pavlova Z, et al. The spectrum of pathological changes in the lung in children with the acquired immunodeficiency syndrome: an autopsy study of 36 cases. Hum Pathol 1994; 25:877-82
70. Morrison DL, Granton JT, Kesten S, et al. Cavitary aspergillosis as a complication of AIDS. Can Assoc Radiol J 1993; 44:35-38
71. Niedt GW, Schinella RA. Acquired immunodeficiency syndrome: clinicopathologic study of 56 autopsies. Arch Pathol Lab Med 1985; 109:727-34
72. Rodrigues ACAR, Basilio CA, Moraes ALR, et al. Pulmonary opportunistic pathogens in AIDS: a hundred autopsies study in Brazil [abstract No. Pub. B. 1055]. In: Program and abstracts of the XI International Conference on AIDS, Vancouver, 1996
73. Rodriguez AF, von Wichmann M, Arrizabalaga J, et al. Lung cavitation and HIV infection: a study of 66 cases [abstract No. Th. A. 4066]. In: Program and abstracts of the XI International Conference on AIDS, Vancouver, 1996
74. Singh G, Wijesurendra CS, Green JT. Disseminated aspergillosis in the acquired immunodeficiency syndrome. Int J STD AIDS 1994; 5:63-66
75. Tiab M, Canfrere I, Hamidou M, et al. Pulmonary aspergillosis can be an early AIDS event [abstract No. PO-B17-1798]. In: Program and abstracts of the Ninth International Conference on AIDS/Fourth STD World Congress (Berlin). London: Wellcome Foundation, 1993
76. Torrents C, Alvarez-Castells A, de Vera PV, et al. Postpneumocystis aspergilloma in AIDS: CT features. J Comput Assist Tomogr 1991; 15:304-07
77. Wood C, Keating J, Nelson MR, et al. Pulmonary aspergillosis in four patients with advanced AIDS [abstract No. PO-B09-1363]. In: Program and abstracts of the Ninth International Conference on AIDS/Fourth STD World Congress (Berlin). London: Wellcome Foundation, 1993
78. Wright EJ, Eisen D, Hurley J, et al. A cluster of seven cases of Aspergillus fumigatus occurring in AIDS patients [abstract No. PuB. 7254]. In: Program and abstracts of the Eighth International Conference on AIDS (Amsterdam). Amsterdam: CONGREX Holland BV, 1992
79. Markowitz GS, Concepcion L, Factor SM, et al. Autopsy patterns of disease among subgroups of an inner-city AIDS population. J Acquir Immune Defic Syndr Hum Retrovirol 1996; 13:48-54
80. Pisani RJ, Wright AJ. Clinical utility of bronchoalveolar lavage in immunocompromised hosts. Mayo Clin Proc 1992; 67:221-27
81. Bonazzi L, Rosini G, Bicocchi R, et al. Pulmonary aspergillosis (PA) in AIDS: Italian experience [abstract No. PO-B17-1792]. In: Porgram and abstracts of the Ninth International Conference on AIDS/Fourth STD World Congress (Berlin). London: Wellcome Foundation, 1993
82. Henochowicz S, Mustafa M, Lawrinson WE, et al. Cardiac aspergillosis in acquired immune deficiency syndrome. Am J Cardiol 1985; 55:1239-40
83. Lewin SR, Hoy J, Crowe SM, et al. The role of bronchoscopy in the diagnosis and treatment of pulmonary disease in HIV-infected patients. Aust N Z J Med 1995; 25:133-39
84. Marques HHS, Valada MG, Sato HK, et al. Misdiagnosis in vertically HIV infected children: analysis of causes of death [abstract No. Th. B. 4318]. In: Program and abstracts of the XI International Conference on AIDS, Vancouver, 1996
85. Masur H, Michelis MA, Wormser GP, et al. Opportunistic infection in previously healthy women: initial manifestations of a community-acquired cellular immunodeficiency. Ann Intern Med 1982; 97:533-39
86. Matheron S, Bartczak S, Mas S, et al. Clinical outcome in 35 adults infected with HIV-2 (1985-1990) [abstract No. 3117]. In: Program and abstracts: VI International Conference on AIDS, San Francisco, 1990
87. Viviani MA, Tortorano AM, Pagano A, et al. European experience with itraconazole in systemic mycoses. J Am Acad Dermatol 1990; 23:587-93
88. Wilkes MS, Fortin AH, Felix JC, et al. Value of necropsy in acquired immunodeficiency syndrome. Lancet 1988; 1:85-88
89. Woods GL, Goldsmith JC. Aspergillus infection of the central nervous system in patients with acquired immunodeficiency syndrome. Arch Neurol 1990; 47:181-84
90. Groll AH, Shah PM, Mentzel C, et al. Trends in the postmortem epidemiology of invasive fungal infection at a university hospital. J Infect 1996; 33:23-32
91. Keating JJ, Rogers T, Petrou M, et al. Management of pulmonary aspergillosis in AIDS: an emerging clinical problem. J Clin Pathol 1994; 47:805-09
92. Rolston KVI, Rodriguez S. Pulmonary aspergillosis in AIDS [letter]. N Engl J Med 1991; 325:356
93. Schouwink JH, Weigel HM, Blaauwgeers JLG, et al. Aspergilloma formation in a pneumatocele associated with Pneumocystis carinii pneumonia. AIDS 1997; 11:135-37
94. Denning DW. Invasive aspergillosis. Clin Infect Dis 1998; 26: 781-805
95. Duthie R, Denning DW. Aspergillus fungemia: report of two cases and review. Clin Infect Dis 1995; 20:598-605
96. Aisner J, Murillo J, Schimpff SC, et al. Invasive aspergillosis in acute leukemia: correlation with nose cultures and antibiotic use. Ann Intern Med 1979; 90:4-9
97. D'Silva H, Burke JF Jr, Cho SY. Disseminated aspergillosis in a presumably immunompetend host. JAMA 1982; 248: 1495-97
98. Brown E, Freedman S, Arbeit R, et al. Invasive pulmonary aspergillosis in an apparently nonimmunocompromised host. Am J Med 1980; 69:624-27
99. Jaffe HW, Bregman DJ, Selik RM. Acquired immune deficiency syndrome in the United States: the first 1,000 cases. J Infect Dis 1983; 148:339-45
100. Schaffner A. Acquired immune deficiency syndrome: is disseminated aspergillosis predictive of underlying cellular immune deficiency? J Infect Dis 1984; 149:828-29
101. Selik RM, Starcher ET, Curran JW. Opportunistic diseases reported in AIDS patients: frequencies, associations and trends. AIDS 1987; 1:175-82
102. Srivastava VM, Krishnaswami H, Srivastava A, et al. Infections in hematological malignancies: an autopsy of 72 cases. Trans R Soc Trop Med Hyg 1996; 90:406-08
103. Orr DP, Myerowitz RL, Dubois PJ. Patho-radiologic correlation of invasive pulmonary aspergillosis in the compromised host. Cancer 1978; 41:2028-39
104. Miller R. HIV-associated respiratory diseases. Lancet 1996; 348:307-12
105. Pitkin AD, Grant AD, Foley NM, et al. Changing patterns of respiratory disease in HIV positive patients in a referral centre in the United Kingdom between 1986-7 and 1990-1. Thorax 1993; 48:204-07
106. Berenguer J, Allende MC, Lee JW, et al. Pathogenesis of pulmonary aspergillosis: granulocytopenia versus cyclosporine and methylprednisolone-induced immunosuppression. Am J Respir Crit Care Med 1995; 152:1079-86
107. Gerson SL, Talbot GH, Hurwitz S, et al. Prolonged granulocytopenia: the major risk factor for invasive pulmonary aspergillosis in patients with acute leukemia. Ann Intern Med 1984; 100:345-51
108. Meyer RD, Young LS, Armstrong D, et al. Aspergillosis complicating neoplastic disease. Am J Med 1973; 54:6-15
109. Morrison CJ, Brummer E, Stevens DA. In vivo activation of peripheral blood polymorphonuclear neutrophils by gamma interferon results in enhanced fungal killing. Infect Immun 1989; 57:2953-58
110. Rex JH, Bennett JE, Gallin JI, et al. In vivo interferon-gamma therapy augments the in vitro ability of chronic granulomatous disease to damage Aspergillus hyphae. J Infect Dis 1991; 163:849-52
111. Roilides E, Holmes A, Blake C, et al. Defective antifungal activity of monocyte-derived macrophages from human immunodeficiency virus-infected children against Aspergillus fumigatus. J Infect Dis 1993; 168: 1562-65
112. Lazzarin A, Uberti Foppa C, Galli M, et al. Impairement of polymorphonuclear leukocyte function in patients with acquired immunodeficiency syndrome and with lymphadenopathy syndrome. Clin Exp Immunol 1986; 65:105-11
113. Burton JR, Zachery JB, Bessin R, et al. Aspergillosis in four renal transplant recipients: diagnosis and effective treatment with amphotericin B. Ann Intern Med 1972; 77:383-88
114. Nalesnik MA, Meyerowitz RL, Jenkins R, et al. Significance of Aspergillus species isolated from respiratory secretions in the diagnosis of invasive pulmonary aspergillosis. J Clin Microbiol 1980; 11:370-76
115. Schaffner A. Pulmonary aspergillosis in AIDS [letter]. N Engl J Med 1991; 325:355-56
116. Cohen J. Clinical manifestations and management of aspergillosis in the compromised patient. In: Warnock DW, Richardson MD, eds. Fungal infection in the compromised patient. New York: John Wiley, 1991; 118-52
117. Smith PD, Ohura K, Masur H, et al. Monocyte function in the acquired immune deficiency syndrome: defective chemotaxis. J Clin Invest 1984; 74:2121-28
118. Marks WH, Florence L, Lieberman J, et al. Successfully treated invasive pulmonary aspergillosis associated with smoking marijuana in a renal transplant recipient. Transplantation 1996; 61:1771-74
119. Denning DW, Hanson LH, Perlman AM, et al. In vitro susceptibility and synergy studies of Aspergillus species to conventional and new agents. Diagn Microbiol Infect Dis 1992; 15:21-34
120. Bennett JE. Aspergillus species. In: Mandell GL, Bennett JE, Dolin E, eds. Mandell, Douglas and Bennett's principales and practice of infectious diseases. 4th ed (vol 2). New York: Churchill Livingstone, 1995; 2306-11
121. Rinaldi MG. Invasive aspergillosis. Rev Infect Dis 1983; 5:1061-77
122. Bodey GP, Vartivarian S. Aspergillosis. Eur J Clin Microbiol Infect Dis 1989; 8:413-37
123. Martin WJ II. Diagnostic bronchoalveolar lavage in immunocompromised patients with new pulmonary infiltrates. Mayo Clin Proc 1992; 67:296-98
124. Martin WJ II, Smith TF, Sanderson DR, et al. Role of bronchoalveolar lavage in the assessment of opportunistic pulmonary infiltrates: utility and complications. Mayo Clin Proc 1987; 62:549-57
125. Treger TR, Visscher DW, Bartlett MS, et al. Diagnosis of pulmonary infection caused by Aspergillus: usefulness of respiratory cultures. J Infect Dis 1985; 152:572-76
126. Yu VL, Muder RR, Poorsattar A. Significance of isolation of Aspergillus from the respiratory tract in the diagnosis of invasive pulmonary aspergillosis: results from a 3-year prospective study. Am J Med 1986; 81:249-54
127. Cunliffe NA, Denning DW. Uncommon invasive mycoses in AIDS. AIDS 1995; 9:411-20
128. Tomee J, Mannes GP, van der Bij W, et al. Serodiagnosis and monitoring of Aspergillus infections after lung transplantation. Ann Intern Med 1996; 125:197-201
129. Caillot D, Casasnovas O, Bernard A, et al. Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery. J Clin Oncol 1997; 15:139-47
130. Andrews CP, Weiner MH. Aspergillus antigen detection in bronchoalveolar lavage fluid from patients with invasive aspergillosis and aspergillomas. Am J Med 1982; 73:372-80
131. Gold JW, Fisher B, Yu B, et al. Diagnosis of invasive aspergillosis by passive hemagglutination assay of antibody. J Infect Dis 1980; 142:87-94
132. Weiner MH, Talbot GH, Gerson SL, et al. Antigen detection in the diagnosis of invasive aspergillosis: utility in controlled, blinded trials. Ann Intern Med 1983; 99:777-82
133. Morti M, Galvin JR, Barloon TJ, et al. Fungal pulmonary infections after bone marrow transplantation: evaluation with radiography and CT. Radiology 1991; 178:721-26
134. Logan PM, Primack SL, Staples C, et al. Acute lung disease in the immunocompromised host: diagnostic accuracy of the chest radiograph. Chest 1995; 108:1283-87
135. Merino JM, Diaz MA, Ramirez M, et al. Complicated pulmonary aspergillosis with pneumothorax and pneumopericardium in a child with acute lymphoblastic leukemia. Pediatr Hematol Oncol 1995; 12:195-99
136. Martino P, Girmenia C, Venditti M, et al. Spontaneous pneumothorax complicating pulmonary mycetoma in patients with acute leukemia. Rev Infect Dis 1990; 12:611-17
137. Blum U, Windfuhr M, Buitrago-Tellez C, et al. Invasive pulmonary aspergillosis: MRI, CT, and plain radiographic findings and their contribution for early diagnosis. Chest 1994; 106:1151-61
138. Herold CJ, Kramer J, Sertl K, et al. Invasive pulmonary aspergillosis: evaluation with MR imaging. Radiology 1989; 173:717-23
139. Levitz SM. Aspergillosis. Infect Dis Clin North Am 1989; 3:1-18
140. Denning DW. Treatment of invasive aspergillosis. J Infect 1994; 28(suppl 1):25-33
141. White MH, Anaissie EJ, Kusne S, et al. Amphotericin B colloidal dispersion vs amphotericin B as therapy for invasive aspergillosis. Clin Infect Dis 1997; 24:635-42
142. Hiemenz JW, Walsh TJ. Lipid formulations of amphotericin B: recent progress and future directions. Clin Infect Dis 1996; 22(suppl 2):S133-44
143. Mylonakis E, Chalevelakis G, Saroglou G, et al. Efficacy of deoxycholate amphotericin B and liposomal amphotericin B in prophylaxis of experimental Aspergillus fumigatus endocarditis. Mayo Clin Proc 1997; 72:1022-27
144. Vassiloyanakopoulos A, Mylonakis E, Butsikakis J, et al. Therapeutic efficacy of amphotericin B and liposomal amphotericin B in the Aspergillus fumigatus rabbit endocarditis model [abstract No. 422]. In: Program and abstracts of the Sixth International Congress for Infectious Diseases, Prague, 1994
145. Kauffman CA. Role of azoles in antifungal therapy. Clin Infect Dis 1996; 22(suppl 2):S148-53
146. Dupont B. Itraconazole therapy in aspergillosis: study in 49 patients. J Am Acad Dermatol 1990; 23:607-14
147. Bodey GP. Azole antifungal agents. Clin Infect Dis 1992; 14(suppl 1):S161-69
148. Grant SM, Clissold SP. Itraconazole: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in superficial and systemic mycoses. Drugs 1989; 37:310-44
149. Como JA, Dismukes WE. Oral azole drugs as systemic antifungal therapy. N Engl J Med 1994; 330:263-72
150. Denning DD, Venkateswarlu K, Oakley KL, et al. Itraconazole resistance in Aspergillusfumigatus. Antimicrob Agents Chemother 1997; 41:1364-68
151. Schulze GE. Oral azole drugs as systemic antifungal therapy [letter]. N Engl J Med 1994; 330:1759-60
152. Villars W, Jones TC. Special features of the clinical use of oral terbinafine in the treatment of fungal diseases. Br J Dermatol 1992; 126(suppl 39):61-69
153. Schiraldi GF, Cicero SL, Colombo MD, et al. Refractory pulmonary aspergillosis: compassionate trial with terbinafine. Br J Dermatol 1996; 134(suppl 46):25-29
154. Mylonakis E, Rich J, Skolnik P, et al. Invasive Aspergillus sinusitis in patients with human immunodeficiency virus infection: report of two cases and review. Medicine 1997; 76:249-55
155. Wallace TL, Paetznick V, Cossum PA, et al. Activity of liposomal nystatin against disseminated Aspergillus fumigatus infection in neutropenic mice. Antimicrob Agents Chemother 1997; 41:2238-43
156. Hata K, Kimura J, Miki H, et al. In vitro and in vivo antifungal activities of ER-30346, a novel oral triazole with a broad antifungal spectrum. Antimicrob Agent Chemother 1996; 40:2237-42
157. Hanson LH, Clemons KV, Denning DW, et al. Efficacy of oral saperconazole in systemic mutine aspergillosis. J Med Vet Mycol 1995; 33:311-17
158. Allendoerfer ZR, Loebenberg D, Rinaldi MG, et al. Evaluation of SCH51048 in an experimental model of pulmonary aspergillosis. Antimicrob Agents Chemother 1995; 39:1345-48
159. Abruzzo GK, Flattery AM, Gill CJ, et al. Evaluation of water-soluble pneumocandin analogs L-733560, L-705589, and L-731373 with mouse models of disseminated aspergillosis, candidiasis, and cryptococcosis. Antimicrob Agents Chemother 1995; 39:1077-81
160. Paya CV. Fungal infections in solid-organ transplantation. Clin Infect Dis 1993; 16:677-88
161. von Eiff M, Roos N, Schulten R, et al. Pulmonary aspergillosis: early diagnosis improves survival. Respiration 1995; 62:341-47
162. Sarosi GA, Davies SF. Therapy for fungal infections. Mayo Clin Proc 1994; 69:1111-17
163. Andriole VT. Infections with Aspergillus species. Clin Infect Dis 1993;17(suppl 2):S481-86
164. Patterson TF, George D, Kordick D, et al. The efficacy of combination therapy with fluconazole and amphotericin B in experimental invasive aspergillosis [abstract No. 584]. In: Program and abstracts of the 31st Interscience Conference on Antimicrobial Agents and Chemotherapy (Washington, DC). Washington, DC: American Society for Microbiology, 1991
165. Heinemann V, Bosse D, Jehn U, et al. Pharmacokinetics of liposomal amphotericin B (AmBisome) in critically ill patients. Antimicrob Agents Chemother 1997; 41:1275-80
166. Mayer JM, Nimer L, Carroll K. Isolated pulmonary aspergillar infection in cardiac transplant recipients: case report and review. Clin Infect Dis 1992; 15:698-700